Military veterans of US' 'toxic soup' Uzbekistan base fighting for proper care 20 years after its shutter
Print Close
By Morgan Phillips
Published May 26, 2025
At the former Soviet base-turned-CIA black site and U.S. military base in Uzbekistan, researchers knew early on danger lingered not just from the enemy but from the ground itself.
Karshi-Khanabad Air Base, known as K2, was a launchpad for U.S. operations into Afghanistan after 9/11. But for thousands of American troops who served there, it may have been a death sentence.
Matthew "Nick" Nicholls, an Army environmental technician and preventive medicine specialist, was part of an early team that assessed the environmental hazards at K2.
"It is probably the most toxic soup of chemicals that any service member has ever been exposed to," Nicholls told Fox News Digital.
Yellowcake uranium oozed from the ground. Jet fuel and volatile chemicals from decaying Soviet rocket bunkers polluted the soil and air. Dangerous fumes hung over the base like the fog of forgotten war.
Nicholls and his team warned commanders, providing recommendations like laying down gravel to suppress toxic dust and restrictions on how long personnel could work in high-risk zones. Some precautions were taken, others weren't.
"People that I am friends with are actively dying from cancer right now," Nicholls said. "These are weird ontologies that are striking down people who are very young, people in their 20s, 30s, 40s, in the prime of their life."
K2 veterans have reported a disturbing trend of rare and aggressive cancers, reproductive organ diseases, osteoarthritis and sudden, unexplained deaths.
VICTIM SPEAKS OUT AFTER NAVY DENIES FUEL-CONTAMINATED WATER CAUSED INJURIES: 'AFFECTED IN NEARLY EVERY WAY'
"These are not the cancers that young people normally get," Nicholls said. "Their stories are not really able to be told. That's the tragedy of it."
"These people went there right after 9/11 to avenge the deaths of those who were murdered," Nicholls said. "Yet we had this launching pad in Uzbekistan that was left in such derelict condition by the Soviets."
Between 2001 and 2005, more than 15,000 U.S. service members passed through K2. Thousands more served as contractors. Many now find themselves struggling to get adequate medical care or recognition from the Department of Veterans Affairs (VA).
The VA recognizes such veterans "may have encountered several hazardous exposures," and the Department of Defense conducted an initial study to look at cancer outcomes. But that study was based only on a few cases of each type of cancer and should not be viewed as "definitive evidence of an association with service at K-2," the VA says.
But a spokesperson for Rep. Mark Green said he does not believe these studies were enough, that they did not take the full extent of contamination into account and did not appropriately inform occupants of the base of their exposure risk or account for the full range of diseases that can result from toxic exposures.
"That is why Rep. Green's NDAA (National Defense Authorization Act) amendment calls for a new, fully rigorous epidemiological study to cover these blind spots," the spokesperson said. "There are too many unknowns to call it a case closed."
Fox News Digital has reached out to the VA for comment.
Green, R-Tenn., and Rep. Stephen Lynch, D-Mass., introduced a provision in the 2021 National Defense Authorization Act requiring the Pentagon to complete a study on K2 exposure within 180 days. Four years later, that study remains unfinished.
"This is unjust," Green told Fox News Digital. "There were repeated warnings that service members were being exposed to toxins, and yet their health and safety were ignored by Pentagon leadership of that day."
In a letter first obtained by Fox News Digital that went out late Friday, Green is pressing the Pentagon to complete the long-overdue study, a step he argues is essential to ensure K2 veterans receive the care they deserve.
"Because this study has yet to be completed (as far as Congress is aware), many K2 veterans are still waiting to receive much needed care," he wrote. "This is unjust. There were repeated warnings at Camp Stronghold Freedom that servicemembers (sic) were being exposed to toxins, and yet their health and safety were ignored by the Pentagon leadership of that day."
The Pentagon told Fox News Digital it would respond to Green privately.
'LIKE A CAR CRASH': NAVY FIGHTER PILOT DESCRIBES BRAIN INJURY PHENOMENON NOW AT CENTER OF CONGRESSIONAL PROBE
In 2024, the VA moved to expand access to disability for K2 veterans and lower the burden of proof for the veterans to link their illnesses to their service. But advocates say it wasn't enough.
"The VA is dragging its feet," Green said. "I think it really purely comes down to cost. I get that the VA wants to be judicious, but my God, the numbers here are so convincing. This is long past due."
Green has also introduced new legislation requiring the VA to formally recognize links between K2 toxic exposure and diseases like cancer, ensuring affected veterans qualify for care and benefits.
Toxins at K2 included petrochemicals, volatile organic compounds, depleted uranium, burn pits and tetrachlorethylene, all chemicals associated with long-term health risks.
But K2 veterans are not specifically named in the PACT Act, which expanded coverage for other toxic exposures like Agent Orange and burn pits.
Green, a physician and Army veteran, sees disturbing echoes of past delays.
CLICK TO GET THE FOX NEWS APP
"Bureaucrats come and go, and bureaucrats have their own agendas," he said. "I want to make sure that it's written in stone and that these guys are not forgotten." Print Close
URL
https://www.foxnews.com/politics/military-veterans-us-toxic-soup-uzbekistan-base-fighting-proper-care-20-years-after-its-shutter
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
2 hours ago
- CBS News
ICE official details risks for staff and detainees in Djibouti, including malaria and potential rocket attacks
A top Immigration and Customs Enforcement official on Thursday detailed what she said were deplorable and unsafe conditions faced by ICE staff and a group of migrants with criminal records who were transferred to a U.S. military base in the African country of Djibouti after a federal judge blocked officials from deporting them to South Sudan. Melissa Harper, the No. 2 official in the ICE division responsible for deportations, revealed in a sworn declaration in federal court in Massachusetts that the detainees are being held in a shipping container repurposed as a conference room inside Camp Lemonnier, a U.S. Navy installation. Eight migrant detainees from Asia, Latin America and South Sudan who had been convicted of serious crimes in the U.S. were flown to the base last month after a judge said they could not be sent to South Sudan without being given a chance to contest their deportation. U.S. military aircraft at Camp Lemonnier in Djibouti on Jan. 21, 2024. Getty Images Harper outlined a series of concerns about the arrangement, describing inadequate security equipment, illness among government employees and 100-degree outdoor temperatures. She detailed risks from exposure to malaria, nearby burn pits and potential attacks from terrorists in Yemen, presumably the Houthis. Officials have said the men currently detained in Djibouti — who hail from Cuba, Laos, Mexico, Myanmar, South Sudan and Vietnam — were convicted of murder, sexual offenses and other serious crimes and had been ordered deported from the U.S. Harper said the detainees were placed in a converted shipping container at the naval base because it was "the only viable place to house them." There are 11 ICE officers assigned to guard the detainees, and two ICE employees serving as medical staff. Those officers, Harper said, "do not have the capacity to maintain constant surveillance, custody, and care" of the detainees. "Only one alien is allowed to use the toilet or shower at a time, and one officer is required to escort the alien. Aliens are permitted to shower every other day, and showers occur at night due to the heat," Harper wrote, adding that the room is "not equipped nor suitable for detention of any length, let alone for the detention of high-risk individuals." Due to limited lighting in the room, both the detainees and the officers are all at risk if an altercation were to occur, Harper wrote. Harper said burn pits in close proximity to the military base, used by locals as a way of eliminating trash and waste, have resulted in a "smog cloud" that has made breathing difficult for ICE officials. "Within 72 hours of landing in Djibouti, the officers and detainees began to feel ill," Harper wrote. "ICE officers continue to feel ill with symptoms such as coughing, difficulty breathing, fever, and achy joints. These symptoms align with bacterial upper respiratory infection, but ICE officers are unable to obtain proper testing for a diagnosis." Some medicine has been used to manage the symptoms, but Harper said it's "unknown" how long the medical supply will last. In addition to respiratory infection fears, Harper said everyone disembarked the plane initially destined for South Sudan without being on anti-malaria medication, resulting in an "unknown degree of exposure" to the disease. Harper said ICE officials were warned by Department of Defense personnel about an "imminent danger of rocket attacks from terrorist groups in Yemen." She said ICE staff lack body armor that would protect them from any such attacks. In a statement, Department of Homeland Security spokeswoman Tricia McLaughlin faulted the Massachusetts federal judge who blocked the deportations to South Sudan for the conditions in Camp Lemonnier, accusing him of "putting the lives of our ICE law enforcement in danger by stranding them in Djibouti without proper resources, lack of medical care, and terrorists who hate Americans running rampant." That judge, Brian Murphy, ordered the Trump administration to halt the planned deportations to South Sudan after lawyers informed him of a flight to that African country that had already taken off. He cited a previous ruling he issued in April that barred officials from deporting migrants to third countries, without affording them certain due process rights first. Murphy subsequently ordered the government to allow the would-be deportees to be interviewed by U.S. asylum officers to determine whether they could be tortured in South Sudan, the world's youngest country and a nation plagued by political turmoil, conflict and violence. He said those interviews could be conducted in the U.S. or overseas. Resources from the Defense Department are being used to care for the detainees, according to Thursday's court filing, which is "causing disruption" to the base's operations and depleting resources meant for service members. Officials at the base, the filing said, have also expressed frustration about holding detainees with violent criminal records near Defense Department living quarters. According to the Navy, the base supports nearly 4,000 military, civilian, and defense contractor personnel from the U.S. and other allied countries.
Yahoo
7 hours ago
- Yahoo
Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain
Follow-on study ('PoC 2') builds on initial success in pancreatic cancer pain Ethics committee authorization supports platform expansion into visceral cancer pain for proprietary ablation technology Expansion supports Autonomix's strategy to build long-term value through multi-indication growth Patient enrollment expected to begin in June 2025 THE WOODLANDS, TX, June 05, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ('Autonomix' or the 'Company'), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it has received Ethics Committee authorization from the Ministry of Health of the Republic of Uzbekistan to open the clinical trial site for the follow-on phase to its proof-of-concept human clinical trial ('PoC 2') evaluating the safety and effectiveness of delivering transvascular energy to ablate relevant problematic nerves and mitigate cancer pain. The Company is on track to commence enrollment in June 2025. 'This next phase of our clinical program represents a meaningful advancement for Autonomix,' said Brad Hauser, CEO of Autonomix. 'With Ethics Committee approval, we can now expand our evaluation beyond severe pancreatic cancer pain to include a broader range of visceral cancers. The initial phase of our study in late-stage pancreatic cancer patients delivered promising results, demonstrating significant pain reduction, substantial decreases in opioid use, and meaningful improvements in quality of life. These outcomes reinforce our belief that Autonomix's technology has the potential to address multiple cancer indications with significant unmet need and transform the standard of care. As we build on this momentum, we see a clear opportunity to create long-term value by unlocking a broader set of impactful clinical applications.' As previously announced, based on the positive results demonstrated in the initial phase of the Company's first-in-human proof-of-concept trial ('PoC 1') in patients with severe pancreatic cancer pain, Autonomix is initiating a follow-on PoC 2 phase in a market expansion opportunity, which has the potential to double the addressable market beyond pancreatic cancer pain by evaluating additional visceral cancers that signal pain through the Celiac Plexus and earlier stage pancreatic cancers with moderate to severe pain. Autonomix's technology constitutes a platform with the potential to address dozens of indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. The PoC 2 phase will provide a concentrated focus on interventional cancer pain management applications like pancreatic, gall bladder, liver, and bile duct, with potential further expansion in oncology, gastroenterology, and other sectors where the Company has established key opinion leader relationships and emerging preclinical evidence. For more information about the Company's technology, please visit About Autonomix Medical, Inc. Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company's first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States. For more information, visit and connect with the Company on X, LinkedIn, Instagram and Facebook. Forward Looking Statements Some of the statements in this release are 'forward-looking statements,' which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the timing of the commencement of the PoC 2 phase of the trial. Such forward-looking statements can be identified by the use of words such as 'should,' 'might,' 'may,' 'intends,' 'anticipates,' 'believes,' 'estimates,' 'projects,' 'forecasts,' 'expects,' 'plans,' and 'proposes.' Although Autonomix believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading 'Risk Factors' and elsewhere in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission ('SEC') on May 31, 2024 and in other filings made by us from time to time with the SEC. Forward-looking statements speak only as of the date of the document in which they are contained and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law. Investor and Media ContactJTC Team, LLCJenene Thomas908.824.0775autonomix@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Miami Herald
a day ago
- Miami Herald
List of Cities Hosting 50501 Protests on June 6
Veterans and military families across the nation will be staging a protest on June 6 as a way to fight for stronger benefits and push back against federal Veterans Affairs job cuts enacted by President Donald Trump's administration. The protests at the National Mall in Washington and many other cities are part of 50501 Veterans, a nonviolent group that works to advance veteran and military member causes. "America made a promise to its veterans. It's a promise we intend to keep," the movement 50501 Veterans said on "Veteran jobs, healthcare, and essential VA services are under attack. We will not stand by." The Department of Veterans Affairs (VA) let go of more than 1,000 staff members in February as part of Trump's government efficiency cuts. The VA said the dismissals "are part of a government-wide Trump Administration effort to make agencies more efficient, effective and responsive." This will allow the VA to focus "on its core mission: providing the best possible care and benefits to Veterans, their families, caregivers and survivors." Since then, the department has sought to cut its workforce by 17 percent, which would mean eliminating about 82,000 staff members. The national June 6 protest is taking place at 2 p.m. ET at the National Mall, just north of the Smithsonian National Air and Space Museum, where 6th Street crosses the Mall. Protest organizers hope the event can be a way to push back against the thousands of veterans who have been fired from federal jobs and the state of veteran health care, protect veteran and military family member employment in the federal workforce and stop the privatizing of the Department of Veterans Affairs under the Trump administration. The list of protests happening across the country on June 6 includes cities like Austin, Houston, New Orleans, New York and Seattle, as well as smaller communities in various states. The full list of the locations holding a protest on June 6 is posted here. Newsweek reached out to 50501 and the Department of Veterans Affairs for comment via email. The group 50501 Veterans is a non-partisan coalition of veterans committed to strategizing, mobilizing and taking action on critical issues affecting our community and beyond, according to The website says the group is united by its shared oath to the Constitution and harnesses its skills and leadership experience to drive meaningful change. "As supporters of the 50501 Movement, we stand firmly for nonviolence and for fostering thoughtful discussion, action-oriented planning, and collaboration on initiatives that uplift veterans, advocate for key causes, and shape policy," the website says. "Whether organizing events, supporting advocacy efforts, or building a strong network, we empower veterans to continue serving in a new and impactful way." The 50501 movement stresses that it is peaceful and "violence of any kind will not be tolerated." The movement's first "protests were a decentralized rapid response to the anti-democratic and illegal actions of the Trump administration and its plutocratic allies. The idea-50 protests in 50 states on 1 day-spread rapidly on social media. In just days earlier this year, grassroots organizers pulled off more than 80 peaceful protests in all 50 states. Since then, the protests have grown over successive days of action: February 17, March 4, April 5 and 19, and May 1. Carlos Álvarez-Aranyos, the founder of American Opposition, which is working alongside 50501 Veterans, told Newsweek: "We organized this action to stand up for our veterans. We believe that a nation that neglects its veterans is a nation that has lost its moral compass. That a government that breaks its promises to those who served cannot be trusted to keep promises to anyone else." Unite for Veterans, on its website: "Veterans and military family members are being fired by the thousands from federal jobs. Our healthcare is being gutted. Our benefits are under siege. This isn't the first time veterans have had to fight for what was promised. From the Bonus Army of 1932 to the battles for the GI Bill and Agent Orange care, veterans have always led the charge for justice." Veterans, family members and their supporters will hold the event on June 6 at 2 p.m. ET. While the main protest is happening in Washington, organizers have planned local demonstrations around the country. It is unclear whether the protests will trigger any significant change at the Department of Veterans Affairs. Related Articles Pete Hegseth Renaming Harvey Milk Navy Ship Sparks Fury From Veterans GroupThousands of Veterans to March on DC Over Feared Cuts-'Will Not Stand By'Veteran's Daughter Living in US 48 years Locked Up by ICEVA Disability Benefits: Payment Worth up to $4,544 Due This Week 2025 NEWSWEEK DIGITAL LLC.
